DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Hematology: Lenalidomide plus dexamethasone is effective in multiple myeloma.

Author(s): Meijer E, Sonneveld P

Affiliation(s): Department of Hematology, Erasmus University MC, Rotterdam, The Netherlands. e.meijer.2@erasmusmc.nl

Publication date & source: 2009-05, Nat Rev Clin Oncol., 6(5):247-8.

Publication type: Comment

A prospective subgroup analysis of two prospective, randomized, double-blind, placebo-controlled phase III clinical trials showed that the combination of lenalidomide plus dexamethasone is superior to dexamethasone alone in patients with relapsed or refractory multiple myeloma who had been previously treated with thalidomide; the implications for clinical practice are discussed.

Page last updated: 2009-10-20

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017